A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Takeda
Disc Medicine, Inc
Incyte Corporation
Ossium Health, Inc.
IGF Oncology, LLC
Keros Therapeutics, Inc.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Cellphire Therapeutics, Inc.
Novartis
Merck Sharp & Dohme LLC
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Celgene
Celgene
Jasper Therapeutics, Inc.
CTI BioPharma
Traws Pharma, Inc.
Traws Pharma, Inc.
Neovii Biotech
Traws Pharma, Inc.
Novartis
Seagen Inc.
Merck Sharp & Dohme LLC
Mesoblast, Ltd.
Cellerant Therapeutics
Texas Oncology Cancer Center
Daiichi Sankyo
Celgene
Celgene